Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities
Lionel Aurelien Kankeu Fonkoua, Olivia Sirpilla, Reona Sakemura, et al.
Molecular Therapy — Oncolytics (2022) Vol. 25, pp. 69-77
Open Access | Times Cited: 148

Showing 26-50 of 148 citing articles:

Combination autologous stem cell transplantation with chimeric antigen receptor T-cell therapy for refractory/relapsed B-cell lymphoma: a single-arm clinical study
Danyang Li, Rui Liu, Zhonghua Fu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
CLINICAL DEVELOPMENT OF IMMUNO-ONCOLOGY THERAPEUTICS
Jianxin Wang, Qi Chen, Qi Shan, et al.
Cancer Letters (2025), pp. 217616-217616
Closed Access | Times Cited: 1
Enhancing immunotherapy with tumour-responsive nanomaterials
Stephen W. Linderman, Louis DeRidder, Lucía Sanjurjo, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access | Times Cited: 1
Therapeutic Targeting of Cancer-Associated Fibroblasts in the Non-Small Cell Lung Cancer Tumor Microenvironment
Yasushi Shintani, Tōru Kimura, Soichiro Funaki, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 335-335
Open Access | Times Cited: 20
Immunomodulatory effect of locoregional therapy in the tumor microenvironment
Lin Xie, Zhiqiang Meng
Molecular Therapy (2023) Vol. 31, Iss. 4, pp. 951-969
Open Access | Times Cited: 19
CAR-T State of the Art and Future Challenges, A Regulatory Perspective
Lorenzo Giorgioni, Alessandra Ambrosone, Maria Francesca Cometa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11803-11803
Open Access | Times Cited: 19
Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy
Colleen Foley, Sheridan L. Swan, Melody A. Swartz
The Journal of Immunology (2024) Vol. 212, Iss. 2, pp. 188-198
Closed Access | Times Cited: 7
Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances
Tingrui Zhang, Zongguang Tai, Fengze Miao, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 372-396
Closed Access | Times Cited: 7
The Tumor Stroma of Squamous Cell Carcinoma: A Complex Environment That Fuels Cancer Progression
Alexandra Buruiană, Bogdan‐Alexandru Gheban, Ioana‐Andreea Gheban‐Roșca, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1727-1727
Open Access | Times Cited: 7
HER2-targeting CAR-T cells show highly efficient anti-tumor activity against glioblastoma both in vitro and in vivo
Xueying Li, Lifen Zhao, Wenzhe Li, et al.
Genes and Immunity (2024) Vol. 25, Iss. 3, pp. 201-208
Open Access | Times Cited: 7
Synthetic biology approaches for improving the specificity and efficacy of cancer immunotherapy
Bo Zhu, Hang Yin, Di Zhang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 5, pp. 436-447
Open Access | Times Cited: 6
From mechanism to therapy: the journey of CD24 in cancer
Kai Zhao, Caifeng Wu, Xiangjun Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
CAR-T cell-derived exosomes: a new perspective for cancer therapy
Farnaz Sani, Shabnam Shojaei, Seyed Amirhossein Tabatabaei, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Universal CAR 2.0 to overcome current limitations in CAR therapy
Lara Sophie Schlegel, Coralie Werbrouck, Michael Boettcher, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Nano-constructs targeting the primary cellular energy source of cancer cells for modulating tumor progression
Krishna Yadav, Deependra Singh, Manju Rawat Singh, et al.
OpenNano (2022) Vol. 8, pp. 100107-100107
Open Access | Times Cited: 26
Four challenges to CAR T cells breaking the glass ceiling
Stefanie R. Bailey, Trisha R. Berger, Charlotte Graham, et al.
European Journal of Immunology (2022) Vol. 53, Iss. 11
Open Access | Times Cited: 26
Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy: A focus on anti PD-1/PD-L1 antibodies
Sajad Najafi, Keywan Mortezaee
Life Sciences (2023) Vol. 338, pp. 122387-122387
Closed Access | Times Cited: 16
Co-expression of IL-4/IL-15-based inverted cytokine receptor in CAR-T cells overcomes IL-4 signaling in immunosuppressive pancreatic tumor microenvironment
Ying Zhou, Muhammad Asad Farooq, Iqra Ajmal, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115740-115740
Open Access | Times Cited: 15
SERS analysis of cancer cell-secreted purines reveals a unique paracrine crosstalk in MTAP-deficient tumors
Pablo S. Valera, Javier Plou, Isabel Garcı́a, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 52
Open Access | Times Cited: 15
Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC
Lőrinc Nagy, Marianna Mezősi-Csaplár, István Rebenku, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review
Bibhu Prasad Satapathy, Pooja Sheoran, Rohit Yadav, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Targeting apoptosis in clear cell renal cell carcinoma
Adam Kowalewski, Jędrzej Borowczak, Mateusz Maniewski, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116805-116805
Open Access | Times Cited: 5
Mechanoimmunology in the solid tumor microenvironment
Matteo Golo, Peter Newman, Daryan Kempe, et al.
Biochemical Society Transactions (2024) Vol. 52, Iss. 3, pp. 1489-1502
Closed Access | Times Cited: 5
Non-Coding RNA in Tumor Cells and Tumor-Associated Myeloid Cells—Function and Therapeutic Potential
Amanda Katharina Binder, Franziska Bremm, Jan Dörrie, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7275-7275
Open Access | Times Cited: 5
Outsmarting trogocytosis to boost CAR NK/T cell therapy
Faezeh Ramezani, Ahmad Reza Panahi Meymandi, Behnia Akbari, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 13

Scroll to top